首页> 外文期刊>Journal of Endocrinological Investigation: Official Journal of the Italian Society of Endocrinology >12(S)-hydroxyeicosatetraenoic acid levels link to coronary artery disease in Type 2 diabetic patients
【24h】

12(S)-hydroxyeicosatetraenoic acid levels link to coronary artery disease in Type 2 diabetic patients

机译:12(S)-羟基二十碳四烯酸水平与 2 型糖尿病患者的冠状动脉疾病有关

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background: 12(S)-Hydroxyeicosatetraenoic acid (12(S)-HETE) is a metabolite of arachidonic acid. 12(S)-HETE is involved in the pathogenesis of atherosclerosis and diabetes. However, the correlation between 12(S)-HETE and coronary artery disease (CAD) in the diabetic patient is unclear. Aims: The study investigated the relationship between 12(S)-HETE and CAD in Type 2 diabetes (T2D). Methods: Plasma 12(S)-HETE levels were detected by enzyme-linked immunosorbent assay in 103 healthy controls (control), 109 diabetic patients without CAD (diabetic), and 152 diabetic patients with CAD (diabetic-CAD). Results: 12(S)-HETE levels were higher in both diabetic and diabetic-CAD groups compared to control and in the diabetic-CAD group compared to the diabetic group. In the multiple linear stepwise regression analysis, 12(S)-HETE levels correlated independently with CAD, systolic blood pressure, and glycated hemoglobin. Conclusions: These results indicate that 12(S)-HETE levels are increased in diabetic patients with CAD, suggesting a role for atherosclerosis in T2D.
机译:背景:12(S)-羟基二十碳四烯酸(12(S)-HETE)是花生四烯酸的代谢产物。12(S)-HETE参与动脉粥样硬化和糖尿病的发病机制。然而,12(S)-HETE与糖尿病患者冠状动脉疾病(CAD)之间的相关性尚不清楚。目的:该研究调查了 2 型糖尿病 (T2D) 中 12(S)-HETE 与 CAD 之间的关系。方法:对103例健康对照(对照)、109例无CAD的糖尿病患者(糖尿病)和152例有CAD(糖尿病-CAD)的糖尿病患者进行酶联免疫吸附试验检测血浆12(S)-HETE水平。结果:与对照组相比,糖尿病组和糖尿病-CAD组的12(S)-HETE水平均高于对照组,糖尿病-CAD组的12(S)-HETE水平高于糖尿病组。在多元线性逐步回归分析中,12(S)-HETE 水平与 CAD、收缩压和糖化血红蛋白独立相关。结论:这些结果表明,糖尿病CAD患者的12(S)-HETE水平升高,表明动脉粥样硬化在T2D中的作用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号